Formulation Development

Formulation Development

Product
Formulation Development
Formulation Development

Information

Quotient Sciences has almost 30 years of experience developing a breadth of pharmaceutical formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,000 molecules at all stages of drug development. - Formulations design - Pre-formulation screening - First-in-human - Solubility enhancement - Modified release - Analytical Services - Process optimization & scale-up - Gamma scintigraphy
Distribution Areas
OceaniaNorth America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
United KingdomUnited States
Main Categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Contract Research Organisations (CROs) (Services)Pharmaceutical Machinery & Technology (Products)
All Categories
Clinical Data ManagementDrug Formulation (general category)Formulation development
Quotient SceincesQuotient Sciences brings 35+ years of trusted scientific insight, quality, and control to drug development with a mission to help our customers bring new molecules to patients faster. We provide a full range of drug product (CDMO) and clinical (CRO) services, which can be tightly integrated with Translational Pharmaceutics(R)—a disruptive platform to enable greater efficiency, better outcomes, and reduced timelines in development.

Log in

See all the content and easy-to-use features by logging in or registering!